Billings Clinic
Especially For:

Clinical Trials

Title   Leukemia (E2906): Newly Diagnosed Acute Myeloid Leukemia in Older Adults
Description   Phase III Trial of Clofarabine Induction & post-Remission Therapy vs. Standard Daunorubcin & Cytarabine Induction & Intermediate Dose Cytarabine Post- Remission Therapy, followed by Decitabine Maintenance vs. Observation in Newly Diagnosed Acute Myeloid Leukemia in Older Adults
IRB Number   CTSU E2906
Category   Leukemia
Inclusion/Notes   Age 60 years or older
No prior chemotherapy except Hydrea
Allogeneic transplant for pts 60-69 w HLA-matched donor

Call contact # below for further Inclusion/Exclusion criteria
Status   Active
Start Date   04/08/2011
Principal Investigator (PI)   Jorge Nieva, MD
Physician Profile   Hematology/Oncology
Contact Name   Linda Allen, RN
Contact Email   lallen@billingsclinic.org
Phone   (406) 435-7484
Alternate Phone   (406) 435-7480
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.